If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Toni Ibrahim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 39 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor

    Itanet (Italian Association for Neuroendocrine Tumours), Lamberti, G., Faggiano, A., Brighi, N., Tafuto, S., Ibrahim, T., Brizzi, M. P., Pusceddu, S., Albertelli, M., Massironi, S., Panzuto, F., Badalamenti, G., Riccardi, F., Butturini, G., Gelsomino, F., De Divitiis, C., Modica, R., Bongiovanni, A., La Salvia, A., Torchio, M. & 3 others, Colao, A., Ferone, D. & Campana, D., 2020, In : The Journal of clinical endocrinology and metabolism. 105, 1, dgz035.

    Research output: Contribution to journalArticle

    Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor

    Lamberti, G., Faggiano, A., Brighi, N., Tafuto, S., Ibrahim, T., Brizzi, M. P., Pusceddu, S., Albertelli, M., Massironi, S., Panzuto, F., Badalamenti, G., Riccardi, F., Butturini, G., Gelsomino, F., De Divitiis, C., Modica, R., Bongiovanni, A., La Salvia, A., Torchio, M., Colao, A. & 2 others, Ferone, D. & Campana, D., Jan 1 2020, In : The Journal of clinical endocrinology and metabolism. 105, 1

    Research output: Contribution to journalArticle

    Open Access
  • Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor

    Lamberti, G., Faggiano, A., Brighi, N., Tafuto, S., Ibrahim, T., Brizzi, M. P., Pusceddu, S., Albertelli, M., Massironi, S., Panzuto, F., Badalamenti, G., Riccardi, F., Butturini, G., Gelsomino, F., De Divitiis, C., Modica, R., Bongiovanni, A., La Salvia, A., Torchio, M., Colao, A. & 2 others, Ferone, D. & Campana, D., 2020, In : The Journal of clinical endocrinology and metabolism. 105, 1

    Research output: Contribution to journalArticle

    Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US Study) from the Italian Sarcoma Group

    Grosso, F., D'Ambrosio, L., Zucchetti, M., Ibrahim, T., Tamberi, S., Matteo, C., Rulli, E., Comandini, D., Palmerini, E., Baldi, G. G., DeCensi, A., Bergaglio, M., Marra, D., Marchesi, E., Siri, G., D'Incalci, M. & Grignani, G., Aug 4 2020, In : Cancer.

    Research output: Contribution to journalArticle